Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 58.70
-1.20 (-2.00%)
Sep 15, 2026, 1:14 PM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.58 billion as of September 15, 2026. Its market cap has decreased by -23.77% in one year.
Market Cap
1.58B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
58.70
ChartMarket Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.58B, a decrease of -21.80%. That is a compound annual growth rate of -5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 1.58B | -20.14% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gwo Xi Stem Cell Applied Technology Co. , | 1.97B |
| Sunny Pharmtech | 1.94B |
| G&E Herbal Biotechnology | 1.83B |
| Andros Pharmaceuticals Co.,Ltd | 1.69B |
| Synbio Tech | 1.55B |
| TaiRx | 1.46B |
| Advagene Biopharma | 1.46B |
| U-Neuron Biomedical | 1.40B |